SCHEMBL6072890

SCHEMBL6072890

O=C(OC1C2CCC1CN(Cc1ccccc1)C2)N1CCc2ccccc2C1c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 7/20 0.61
CHRM2 P08172 2/20 0.61
CHRM1 P11229 2/20 0.61
KCNH2 Q12809 2/20 0.61
CACNA1F O60840 1/20 0.61
CHRM4 P08173 1/20 0.61
CHRM5 P08912 1/20 0.61
KCNE1 P15382 1/20 0.61
KCNQ1 P51787 1/20 0.61
CACNA1D Q01668 1/20 0.61
CACNA1S Q13698 1/20 0.61
CACNA1C Q13936 1/20 0.61
SCN5A Q14524 1/20 0.61
KCND3 Q9UK17 1/20 0.61
HHAT Q5VTY9 2/20 0.47
CYP2D6 P10635 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2B Q13224 1/20 0.46
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29560557 0.93 CHRM3 (0.62) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL6072906 0.82 CHRM3 (0.64) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL6072987 0.81 CHRM3 (0.52) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL1566990 0.79 CHRM3 (0.60) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL22777096 0.78 CHRM3 (0.68) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL22784309 0.78 CHRM3 (0.68) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL29561013 0.78 CHRM3 (0.68) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL19623779 0.77 CHRM3 (0.90) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL6072959 0.76 CHRM3 (0.50) CHRM3CHRM2CHRM1KCNH2CACNA1F
SCHEMBL1567408 0.76 CHRM3 (0.64) CHRM3CHRM2CHRM1KCNH2CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO claimed
WO-2006035280-A1 3,4-DIHYDROISOQUINOLINE COMPOUNDS AS MUSCRINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF RESPIRATORY, URINARY AND GASTROINTESTINAL DISEASES RANBAXY LABORATORIES LIMITED (IN) 2006-04-06 WO disclosed